Skip to main content
TipRanks
Go Ultimate75% OFF

Docebo (DCBO) AI Stock Analysis

407 Followers
DCBO

Docebo

(NASDAQ:DCBO)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Recurring SaaS RevenueThe subscription-based SaaS model creates recurring, relatively predictable revenue from enterprise customers and supports retention over time. Implementation, integrations, and multiple platform modules can deepen customer adoption, strengthening the foundation for durable cash generation.
Negative Factors
Negative Stockholders’ EquityNegative equity materially weakens the balance sheet and reduces financial flexibility even though total debt is not extreme relative to assets. It can constrain capital allocation and leave the company less able to absorb setbacks or fund initiatives internally.

Docebo (DCBO) vs. SPDR S&P 500 ETF (SPY)

-40%-20%0%20%40%60%DCBO+56.71%SPY+13.31%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$749.68M
Dividend Yield
0.00%
Average Volume (3M)
51.46K
Price to Earnings (P/E)
21.8
Beta (1Y)
1.09
Revenue Growth
13.08%
EPS Growth
76.90%
Country
US
Employees
966
Sector
Technology
Sector Strength
61
Industry
Software - Application

Docebo Business Overview & Revenue Model

Company Description

Docebo Inc. develops and provides learning management platform for training in Canada, the United States, and internationally. The company’s cloud platform consists of a learning suite, which includes Docebo Learn platform, a cloud-based learning pla...

Docebo Earnings Call Summary

Earnings Call Date:Nov 06, 2026(Q3-2026)|% Change Since:6.81%|Next Earnings Date:Mar 11, 2027
Earnings Call SentimentPositive

The call was predominantly positive, characterized by raised full-year revenue growth expectations, 34% EBITDA growth, strong government and healthcare pipeline development, expanding AI and Knowledge capabilities, progress in skills intelligence cross-selling, and continued shareholder returns. The main challenges were delayed government deals, foreign-exchange and enterprise deal-timing effects on Q4 guidance, professional-services mix pressure on gross margins, higher debt following the special dividend, and the early-stage nature of several new initiatives.

Positive Updates

Revenue Growth Outlook Raised
Full-year 2026 revenue growth is now projected to be 14% plus, up from the 10.6% midpoint initially guided in February. Quarterly subscription revenue growth was 12% in Q1, 12% in Q2, and 12.4% in Q3, with 12.8% guided for Q4.

Negative Updates

Government Deals Slipped Out of Q3
Although government pipeline development was strong, procurement processes across state, local, and federal agencies can be difficult. Docebo had hoped to close several significant deals in Q3, but they did not arrive during the quarter and are now expected during the fiscal year.

Company Guidance

Docebo projected full-year 2026 revenue growth at “14% plus,” with subscription revenue growth guided at 12.8% in Q4, following 12% in Q1, 12% in Q2, and 12.4% in Q3; Q4 guidance reflects “almost little to none incremental revenues from Q4 bookings,” with those bookings impacting 2027 guidance to be provided in February. The company expects “20% plus EBITDA margins” while investing in health care, FTE, and government, and said there will be “some EBITDA margin expansion” in 2027 and beyond, with R&D expected to “roughly stay flat as a percentage of revenue” and continued leverage in G&A. Q4 gross margin is expected to show a “similar trend,” while the company expects FedRAMP activity to peak in Q4 this year, with “next Q3” expected to be the highest in the next couple years; the FTE model will be validated over the next 3 to 6 months, and health care is expected to start next year.

Docebo Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

DCBO against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TSE:THNCTSE:THNC72OutperformCAD 155.06M-21.94-11.94%―3.19%-1907.14%
TSE:OTEXTSE:OTEX72OutperformCAD 8.54B9.3016.15%4.32%-0.64%37.53%
TSE:ENGHTSE:ENGH68NeutralCAD 973.99M14.0811.70%6.81%-4.73%-5.61%
Sector *61Neutral$37.18B12.37-10.20%1.83%8.50%-7.62%
TSE:NTARTSE:NTAR38UnderperformCAD 11.83M-2.8674.69%―18.40%36.36%

* Technology Sector Average

Performance Comparison

-50%0%50%DCBOTSE:OTEXTSE:MVY.HTSE:ENGHTSE:NTARTSE:THNCDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DCBO and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DCBODocebo, Inc.30.0510.9757.48%
TSE:OTEXOpen Text Corporation35.37-8.89-20.08%
TSE:MVY.HMoovly Media0.010.000.00%
TSE:ENGHEnghouse Systems18.07-0.23-1.24%
TSE:NTARNexTech AR Solutions Corp0.05-0.09-65.52%
TSE:THNCThinkific Labs, Inc.2.300.4222.34%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.